TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35529261

Group type: EXPERIMENTAL
Intervention: Multidisciplinary collaborative extended care (observation group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Evidence-based nursing (comparison group)
Number of subjects: 96
Study: 33145632

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Number of subjects: 107
Study: 34610164

Group type: EXPERIMENTAL
Intervention: Skin needling with 100% trichloroacetic acid (TCA)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Skin needling with bleomycin
Number of subjects: 68
Study: 34702443

Group type: EXPERIMENTAL
Intervention: Calcitriol 0.5 μg per os twice daily for three days before surgery
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group (no calcitriol)
Number of subjects: 246
Study: 36265502

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg intravenously every 3 weeks for 17 cycles)
Number of subjects: 976

Group type: COMPARATOR
Intervention: Placebo (intravenously every 3 weeks for 17 cycles)
Number of subjects: 976
Study: 33940037

Group type: EXPERIMENTAL
Intervention: Mean field model developed to capture disease dynamics in clustered networks.
Number of subjects: 0
Study: 35385361

Group type: EXPERIMENTAL
Intervention: tofacitinib 5 or 10 mg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: adalimumab 40 mg every other week
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 32044505

Group type: EXPERIMENTAL
Intervention: PGE1 treatment (intravenous injection)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular therapy (control group)
Number of subjects: 60
Study: 36214628

Group type: EXPERIMENTAL
Intervention: Therapist-supported acceptance and commitment therapy-based bibliotherapy (bi-weekly therapist support)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Therapist contact only (baseline phase)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Therapist-supported bibliotherapy (intervention phase)
Number of subjects: 16
Study: 35650554

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (load dose 0.5 μg kg−1 over 10 min, followed by maintenance dose 0.2 μg kg−1 h−1)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 110
Study: 32618692

Group type: EXPERIMENTAL
Intervention: Video-assisted reflection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Recall-assisted reflection
Number of subjects: 40
Study: 35142407

Group type: EXPERIMENTAL
Intervention: synTOF
Number of subjects: 377

Group type: COMPARATOR
Intervention: PETRA
Number of subjects: 377

Group type: COMPARATOR
Intervention: TOF
Number of subjects: 377

Group type: COMPARATOR
Intervention: synTOF vs TOF
Number of subjects: 377
Study: 33367763

Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 40
Study: 34916855

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) administered 2 weeks after fertilization for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administered 2 weeks after fertilization for 6 months
Number of subjects: 0
Study: 34384282

Group type: EXPERIMENTAL
Intervention: Oral maraviroc (MVC) 300 mg dosed orally
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MVC 1% gel dosed rectally
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MVC 1% gel dosed vaginally
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 33470602

Group type: EXPERIMENTAL
Intervention: Rest Redistribution (RR)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Traditional Sets (TS)
Number of subjects: 45
Study: 36200403

Group type: EXPERIMENTAL
Intervention: Mailed brochure about BZRA risks and information about a free, online cognitive behavioral therapy for insomnia (CBTI) program (Arm 1)
Number of subjects: 2009

Group type: EXPERIMENTAL
Intervention: Mailed brochure about BZRA risks and telephone reinforcement call (Arm 2)
Number of subjects: 2009

Group type: COMPARATOR
Intervention: Mailed brochure without insomnia treatment information (Arm 3)
Number of subjects: 2009
Study: 34130954

Group type: EXPERIMENTAL
Intervention: Novel community-based group exercise and nutritional intervention (protein supplementation) for 8 weeks
Number of subjects: 0
Study: 35931131

Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy with graft
Number of subjects: 173

Group type: COMPARATOR
Intervention: Vaginal hysterectomy with uterosacral suspension
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Body mass index increase of 5 kg/m2
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Duration of prolapse symptoms increase of 1 year
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Women with obesity
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Women who are overweight
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Women experiencing >5 years of prolapse symptoms
Number of subjects: 173
Study: 35449399

Group type: EXPERIMENTAL
Intervention: POC rapid CYP2C19 genotyping
Number of subjects: 5302

Group type: COMPARATOR
Intervention: No genotyping (control)
Number of subjects: 5302
Study: 32842399

Group type: EXPERIMENTAL
Intervention: Vacuum sealing drainage (VSD)
Number of subjects: 60
Study: 33009189

Group type: EXPERIMENTAL
Intervention: Bevel facing cephalad direction
Number of subjects: 68

Group type: COMPARATOR
Intervention: Bevel facing left (conventional group)
Number of subjects: 68
Study: 33380922

Group type: EXPERIMENTAL
Intervention: Distal transradial artery (dTRA) approach
Number of subjects: 900

Group type: COMPARATOR
Intervention: Conventional transradial artery (TRA) approach
Number of subjects: 900
Study: 36473974

Group type: EXPERIMENTAL
Intervention: Mini-invasive canaliculotomy (minor incision 3 mm)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventional canaliculotomy (long incision 6–8 mm)
Number of subjects: 108
Study: 33549761

Group type: EXPERIMENTAL
Intervention: Depression status
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Depression severity
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption
Number of subjects: 347
Study: 33861375

Group type: EXPERIMENTAL
Intervention: Prednisolone 1 mg/kg/day (low dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prednisolone 2 mg/kg/day (standard dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 32700415

Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression (IPC)
Number of subjects: 448

Group type: COMPARATOR
Intervention: IPC with enoxaparin
Number of subjects: 448
Study: 35550642

Group type: EXPERIMENTAL
Intervention: Standard major trauma centre care plus REBOA
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard major trauma centre care alone
Number of subjects: 120
Study: 34724640

Group type: EXPERIMENTAL
Intervention: Machine Learning (ML) algorithms - Random Forest Classifier (RFC)
Number of subjects: 964

Group type: COMPARATOR
Intervention: Nomogram
Number of subjects: 964
Study: 32975909

Group type: EXPERIMENTAL
Intervention: DHEA 50 mg/d
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 36351794

Group type: EXPERIMENTAL
Intervention: Very early invasive coronary angiography (ICA) within 12 hours of diagnosis
Number of subjects: 452

Group type: COMPARATOR
Intervention: Standard invasive coronary angiography (ICA) within 48-72 hours of diagnosis
Number of subjects: 452
Study: 34181468

Group type: EXPERIMENTAL
Intervention: Top-Down Approach (initial DMSA scan)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Bottom-Up Approach (initial VCUG)
Number of subjects: 500
Study: 32527966

Group type: EXPERIMENTAL
Intervention: Walking at speeds of 0.89, 1.12, 1.34, 1.56, 1.79, 2.01, 2.24, and 2.46 m/s for 3 minutes
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Running at speeds of 1.79, 2.01, 2.24, 2.46, 2.68, 2.91, 3.13, and 3.35 m/s for 3 minutes
Number of subjects: 11

Group type: COMPARATOR
Intervention: Comparison of lower limb attractor stability and sacrum displacement
Number of subjects: 11
Study: 35388512

Group type: EXPERIMENTAL
Intervention: Multicomponent general practice intervention (enrolment with preferred GP, longer appointments, follow-up within 7 days of care episodes)
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Multicomponent general practice intervention
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1044
Study: 34716753

Group type: EXPERIMENTAL
Intervention: Levosimendan (0.1 μg/kg/min as a continuous 24‐h intravenous infusion administered once monthly for 1 year)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 34671856

Group type: EXPERIMENTAL
Intervention: Preoperative systemic inflammatory response biomarkers (SIR-biomarkers) including albumin-globulin ratio (AGR), De Ritis ratio (DRR), and systemic immune-inflammation index (SII).
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: High levels of SII and DRR in the testing cohort.
Number of subjects: 613

Group type: COMPARATOR
Intervention: Exclusion of SIR-biomarkers from the model.
Number of subjects: 613
Study: 34169923

Group type: EXPERIMENTAL
Intervention: Mobile voice call reminders on the second and seventh day after referral
Number of subjects: 310

Group type: COMPARATOR
Intervention: Conventional paper-based referral
Number of subjects: 310
Study: 33687835

Group type: EXPERIMENTAL
Intervention: Part-aware approach for joint part-level car parsing and reconstruction; Dense part information introduced to facilitate pose and shape estimation; Optimized with a novel 3D loss.
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Fusing dense part information for pose and shape estimation.
Number of subjects: 348
Study: 33641770

Group type: EXPERIMENTAL
Intervention: Wellness Incentives and Navigation (WIN) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35383556

Group type: EXPERIMENTAL
Intervention: Active tDCS (2mA, 20 minutes, 3 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study: 32028464

Group type: EXPERIMENTAL
Intervention: Sport-Specific (SS) resistance-band training
Number of subjects: 28

Group type: COMPARATOR
Intervention: General-Training (GT) resistance-band training
Number of subjects: 28
Study: 32971449

Group type: EXPERIMENTAL
Intervention: Nurse-led positive psychology intervention
Number of subjects: 91

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 91
Study: 35146942

Group type: EXPERIMENTAL
Intervention: Simplified dietary self-monitoring of high-calorie foods
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard calorie monitoring
Number of subjects: 72
Study: 34111870

Group type: EXPERIMENTAL
Intervention: Early-Treated (ET) group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Early-Untreated (EUT) group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Full cohort (ET + EUT combined)
Number of subjects: 50
Study: 32611631

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 757601

Group type: COMPARATOR
Intervention: β-blockers
Number of subjects: 757601

Group type: COMPARATOR
Intervention: Genetic predisposition to higher systolic and diastolic BP
Number of subjects: 757601
Study: 35918813

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 43
Study: 32768272

Group type: EXPERIMENTAL
Intervention: Kangaroo care
Number of subjects: 64

Group type: COMPARATOR
Intervention: Oral sucrose
Number of subjects: 64
Study: 35435492

Group type: EXPERIMENTAL
Intervention: Polished with polishing rubbers
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Glaze application - powder/liquid technique
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Polished with polishing rubbers + glaze application - powder/liquid
Number of subjects: 4

Group type: COMPARATOR
Intervention: As-sintered (control)
Number of subjects: 4
Study: 33793794

Group type: EXPERIMENTAL
Intervention: Septum resection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 80
Study: 32867995

Group type: EXPERIMENTAL
Intervention: Bacillus direct-fed microbial (DFM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control rye-based diet
Number of subjects: 50
Study: 36452128

Group type: EXPERIMENTAL
Intervention: Subfascial ultrasound-guided stellate ganglion block
Number of subjects: 50

Group type: COMPARATOR
Intervention: Extrafascial ultrasound-guided stellate ganglion block
Number of subjects: 50
Study: 34379337

Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) plus Daclatasvir (DCV)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sofosbuvir (SOF) plus Ravidasvir (RDV)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 120
Study: 32735427

Group type: EXPERIMENTAL
Intervention: Instant feedback group
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nonfeedback group
Number of subjects: 25
Study: 35472247

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention (counselling intervention including drug information and answering queries)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 165
Study: 33856395

Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen (1 g every 6 hours for 48 hours)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Placebo (1 g every 6 hours for 48 hours)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 358

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 358
Study: 33208583

Group type: EXPERIMENTAL
Intervention: Goreisan for 3 months (Group G)
Number of subjects: 224

Group type: COMPARATOR
Intervention: No medication (Group N)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Goreisan for 3 months (Group G) in high-risk patients
Number of subjects: 224

Group type: COMPARATOR
Intervention: No medication (Group N) in high-risk patients
Number of subjects: 224
Study: 32584467

Group type: EXPERIMENTAL
Intervention: Deterministic probability-matching strategy
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Randomized probability-matching strategy
Number of subjects: 3

Group type: COMPARATOR
Intervention: Nonadaptive strategy (equal allocation)
Number of subjects: 3
Study: 36443869

Group type: EXPERIMENTAL
Intervention: Group-based cognitive behavioral therapy for insomnia (gCBT-I)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 21
Study: 34116031

Group type: EXPERIMENTAL
Intervention: EUS-FNB with ROSE
Number of subjects: 800

Group type: COMPARATOR
Intervention: EUS-FNB without ROSE
Number of subjects: 800
Study: 32435764

Group type: EXPERIMENTAL
Intervention: EQUIA Forte (glass hybrid restorative system)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Tetric EvoCeram (nanohybrid resin composite)
Number of subjects: 360
Study: 35448974

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 12 weeks, coupled with Behavioral Activation techniques, meeting twice/week.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Attention-control group (Health, Wellness, and Education; HWE) for 12 weeks, meeting twice/week.
Number of subjects: 50
Study: 32991513

Group type: EXPERIMENTAL
Intervention: Braces designed using CAD/CAM (CAD)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Braces designed using CAD/CAM with finite element modeling (CAD-FEM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Both CAD and CAD-FEM braces
Number of subjects: 120
Study: 33342450

Group type: EXPERIMENTAL
Intervention: Individual Placement Support (IPS)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: IPS supplemented with cognitive remediation (IPSE)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Service as Usual (SAU)
Number of subjects: 720
Study: 33450366

Group type: EXPERIMENTAL
Intervention: HIIT (High-Intensity Interval Training)
Number of subjects: 69

Group type: COMPARATOR
Intervention: MICE (Moderate-Intensity Continuous Exercise)
Number of subjects: 69
Study: 33634552

Group type: EXPERIMENTAL
Intervention: Combination oral clindamycin plus rifampicin (C + R)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Oral clindamycin monotherapy (CM)
Number of subjects: 36
Study: 33044376

Group type: EXPERIMENTAL
Intervention: Povidone-iodine (PVP-I) irrigation
Number of subjects: 175

Group type: COMPARATOR
Intervention: Sterile saline (SS) irrigation
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: High-risk subjects
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Low-risk subjects
Number of subjects: 175
Study: 34919488

Group type: EXPERIMENTAL
Intervention: MEPP-website
Number of subjects: 10

Group type: COMPARATOR
Intervention: hobby-designed website
Number of subjects: 10
Study: 32174355

Group type: EXPERIMENTAL
Intervention: Ballpoint pens with specific physical properties (comfortable, fine, refined, deep, natural, heavier, longer, thick and antislip grips, thin nibs, center of gravity close to nib)
Number of subjects: 0
Study: 35644376

Group type: EXPERIMENTAL
Intervention: Clinic Intervention (CI)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: CI with Home Visits (HV)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: CI and real-time feedback to asthma clinician
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: CI with HVs and real-time feedback
Number of subjects: 400
Study: 33565123

Group type: EXPERIMENTAL
Intervention: Integrated community case management (iCCM)
Number of subjects: 5898
Study: 33218540

Group type: EXPERIMENTAL
Intervention: Rib Raising (RR) technique
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fourth Ventricle Compression Technique (CV4)
Number of subjects: 32

Group type: COMPARATOR
Intervention: CV4
Number of subjects: 32
Study: 35060507

Group type: EXPERIMENTAL
Intervention: Orthopedic device (LSM-01)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham device (control group)
Number of subjects: 0
Study: 34344546

Group type: EXPERIMENTAL
Intervention: 100% watermelon juice
Number of subjects: 21

Group type: COMPARATOR
Intervention: isocaloric placebo
Number of subjects: 21
Study: 35275197

Group type: EXPERIMENTAL
Intervention: Radiotherapy and temozolomide
Number of subjects: 159

Group type: COMPARATOR
Intervention: Radiotherapy only
Number of subjects: 159
Study: 33710319

Group type: EXPERIMENTAL
Intervention: β-blocker prescription
Number of subjects: 111718

Group type: EXPERIMENTAL
Intervention: Propranolol and Atenolol
Number of subjects: 111718
Study: 32139762

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (>90% VO2max)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (60-75% VO2max)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (<60% VO2max)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All exercise sessions
Number of subjects: 12
Study: 36532821

Group type: EXPERIMENTAL
Intervention: Right nostril breathing (RNB)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Left nostril breathing (LNB)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Alternate nostril breathing (ANB)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Normal breathing (NB)
Number of subjects: 164
Study: 34701377

Group type: EXPERIMENTAL
Intervention: DI IMPT(chemo)
Number of subjects: 71

Group type: COMPARATOR
Intervention: IMRT(chemo)
Number of subjects: 71
Study: 32978194

Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing by trained and qualified nurses (7 days, 2 sessions per day, 30 min each session)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Usual rehabilitation provided by therapists (7 days, 2 sessions per day, 30 min each session)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing by trained and qualified nurses
Number of subjects: 224

Group type: COMPARATOR
Intervention: Usual rehabilitation provided by therapists
Number of subjects: 224
Study: 35887551

Group type: EXPERIMENTAL
Intervention: Iloprost (ILO) inhalation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 64
Study: 32118565

Group type: EXPERIMENTAL
Intervention: Handheld ultrasound devices (HUDs)
Number of subjects: 149

Group type: COMPARATOR
Intervention: No handheld ultrasound devices (no-HUDs)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: 2017 cohort (HUDs and no-HUDs combined)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Repeated lecture series
Number of subjects: 149
Study: 32533427

Group type: EXPERIMENTAL
Intervention: Insulin loading procedure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Glucose loading procedure
Number of subjects: 60
Study: 33797658

Group type: EXPERIMENTAL
Intervention: Preoperative analgesia (PRE group) using celecoxib, meloxicam or rofecoxib from 2 hours pre-operation to 48 hours post-operation
Number of subjects: 464

Group type: COMPARATOR
Intervention: Postoperative analgesia (POST group) using celecoxib, meloxicam or rofecoxib from 4 to 48 hours post-operation
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Preoperative analgesia (PRE group)
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of analgesics (meloxicam, celecoxib, rofecoxib)
Number of subjects: 464
Study: 34455503

Group type: EXPERIMENTAL
Intervention: Tilted group implants (2 anterior axial and 2 posterior distally inclined implants)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Axial group implants (2 implants in the interforaminal area and 2 in the molar area)
Number of subjects: 20
Study: 33326656

Group type: EXPERIMENTAL
Intervention: Withdrawal combined with preventive medication (W+P)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Withdrawal with optional preventive medication (W)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Preventive medication without withdrawal (P)
Number of subjects: 120
Study: 35261290

Group type: EXPERIMENTAL
Intervention: Invasive management strategy
Number of subjects: 777

Group type: COMPARATOR
Intervention: Conservative management strategy
Number of subjects: 777
Study: 33529350

Group type: EXPERIMENTAL
Intervention: Sunscreens and cosmetic formulations containing ascorbyl tetraisopalmitate and rice peptides
Number of subjects: 60